Literature DB >> 2326002

Blood pressure and retinopathy in type I diabetes.

H P Chase1, S K Garg, W E Jackson, M A Thomas, S Harris, G Marshall, M J Crews.   

Abstract

The relationship between blood pressure and diabetic retinopathy was evaluated in 249 young subjects with type I diabetes. Although hypertension is known to be associated with an increased risk for retinopathy, the effects of high-normal blood pressure are unknown. Retinopathy (158 of 249 subjects, 63%) is considerably more common in a young diabetic population than is hypertension (7 of 249 subjects, 2%). Thus, if blood pressure is important in the etiology or progression of diabetic retinopathy, levels below the hypertensive range (less than 141/90 mmHg) must be considered. The combined effect of hypertension and high-normal blood pressure (greater than 90th percentile but less than 141/90 mmHg) was studied. Elevation in diastolic blood pressure, alone, and in combination with elevated systolic blood pressure, correlated significantly (P less than 0.03) with retinopathy. The presence of high-normal blood pressure resulted in a prospectively higher occurrence of retinopathy and of progression of preexisting retinopathy. Glycohemoglobin (HbA1) and duration of diabetes also correlated with retinopathy. Both good glycemic control and maintenance of diastolic blood pressure below the 90th percentile for age may be important in relation to diabetic retinopathy.

Entities:  

Mesh:

Year:  1990        PMID: 2326002     DOI: 10.1016/s0161-6420(90)32611-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

Review 1.  Hypertension and diabetic retinopathy--what's the story?

Authors:  J T Gillow; J M Gibson; P M Dodson
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

2.  Blood pressure control and diabetic retinopathy.

Authors:  R Klein; B E K Klein
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Macular circulation in patients with diabetes mellitus with and without arterial hypertension.

Authors:  O Arend; M Rüffer; A Remky
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 4.  Update on Screening for Sight-Threatening Diabetic Retinopathy.

Authors:  Peter H Scanlon
Journal:  Ophthalmic Res       Date:  2019-05-27       Impact factor: 2.892

5.  Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.

Authors:  A Castillo; J M Benitez del Castillo; D Diaz; O Sayagues; J L Ruibal; J Garcia-Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

6.  Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy.

Authors:  Wendy W Harrison; Marcus A Bearse; Marilyn E Schneck; Brian E Wolff; Nicholas P Jewell; Shirin Barez; Andrew B Mick; Bernard J Dolan; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

7.  Blood pressure, vessel caliber, and retinal thickness in diabetes.

Authors:  Wendy W Harrison; Ann Chang; Maria G Cardenas; Marcus A Bearse; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Optom Vis Sci       Date:  2012-12       Impact factor: 1.973

8.  Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.

Authors:  J M Benitez del Castillo; A Castillo; P C Fernandez; J Garcia Sanchez
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 9.  Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence.

Authors:  Daniel J Moore; Justin M Gregory; Yaa A Kumah-Crystal; Jill H Simmons
Journal:  Vasc Health Risk Manag       Date:  2009-11-23

Review 10.  Complications of pediatric and adolescent type 1 diabetes mellitus.

Authors:  S J Brink
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.